Avinger Stock Price, News & Analysis (NASDAQ:AVGR)

$1.50 0.00 (0.00 %)
(As of 02/22/2018 03:51 AM ET)
Previous Close$1.50
Today's Range$1.39 - $1.56
52-Week Range$1.25 - $117.43
Volume297,234 shs
Average Volume195,130 shs
Market Capitalization$47.31 million
P/E Ratio-0.02
Dividend YieldN/A
Beta-0.23

About Avinger (NASDAQ:AVGR)

Avinger logoAvinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The Company focuses on introducing products based on its lumivascular platform, which is an intravascular image-guided system. The Company manufactures and sells a suite of products in the United States and certain European markets. The Company's products include Lightbox imaging console, as well as its Wildcat, Kittycat and the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO). The lumivascular platform offers real-time visualization of the inside of the artery during PAD treatment. The lumivascular platform consists of a capital component Lightbox and a range of disposable catheter products, including Ocelot, Ocelot PIXL, Ocelot MVRX and Pantheris.

Receive AVGR News and Ratings via Email

Sign-up to receive the latest news and ratings for AVGR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Imaging Systems
Sub-IndustryN/A
SectorHealthcare
SymbolNASDAQ:AVGR
CUSIPN/A
Phone+1-650-3632400

Debt

Debt-to-Equity RatioN/A
Current Ratio0.36%
Quick Ratio0.26%

Price-To-Earnings

Trailing P/E Ratio-0.0171076642335766
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$19.21 million
Price / Sales0.07
Cash FlowN/A
Price / CashN/A
Book Value$7.44 per share
Price / Book0.20

Profitability

Trailing EPS($87.68)
Net Income$-56,120,000.00
Net Margins-410.07%
Return on EquityN/A
Return on Assets-146.13%

Miscellaneous

Employees197
Outstanding Shares880,000

Avinger (NASDAQ:AVGR) Frequently Asked Questions

What is Avinger's stock symbol?

Avinger trades on the NASDAQ under the ticker symbol "AVGR."

When did Avinger's stock split? How did Avinger's stock split work?

Shares of Avinger reverse split on the morning of Wednesday, January 31st 2018. The 1-40 reverse split was announced on Tuesday, January 30th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, January 30th 2018. An investor that had 100 shares of Avinger stock prior to the reverse split would have 3 shares after the split.

How were Avinger's earnings last quarter?

Avinger Inc (NASDAQ:AVGR) announced its quarterly earnings data on Monday, August, 1st. The medical device company reported ($42.40) earnings per share for the quarter, beating analysts' consensus estimates of ($46.00) by $3.60. The medical device company had revenue of $4.70 million for the quarter, compared to the consensus estimate of $3.05 million. View Avinger's Earnings History.

When will Avinger make its next earnings announcement?

Avinger is scheduled to release their next quarterly earnings announcement on Monday, March, 5th 2018. View Earnings Estimates for Avinger.

Who are some of Avinger's key competitors?

Who are Avinger's key executives?

Avinger's management team includes the folowing people:

  • Jeffrey M. Soinski, President, Chief Executive Officer, Director (Age 54)
  • Matthew B. Ferguson, Chief Business Officer and Chief Financial Officer (Age 49)
  • Sougata Banerjee, Senior Vice President - Operations and Quality (Age 50)
  • Himanshu N. Patel, Chief Technology Officer (Age 57)
  • Philip R. Preuss, Vice President - Marketing and Business Operations (Age 39)
  • James G. Cullen, Non-Executive Chairman of the Board (Age 73)
  • Thomas J. Fogarty M.D., Independent Director (Age 83)
  • Donald A. Lucas Jr., Independent Director (Age 53)
  • James B. McElwee, Independent Director (Age 63)

When did Avinger IPO?

(AVGR) raised $60 million in an IPO on Friday, January 30th 2015. The company issued 4,600,000 shares at a price of $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company served as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers.

How do I buy Avinger stock?

Shares of Avinger can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Avinger's stock price today?

One share of Avinger stock can currently be purchased for approximately $1.50.

How big of a company is Avinger?

Avinger has a market capitalization of $47.31 million and generates $19.21 million in revenue each year. The medical device company earns $-56,120,000.00 in net income (profit) each year or ($87.68) on an earnings per share basis. Avinger employs 197 workers across the globe.

How can I contact Avinger?

Avinger's mailing address is 400 Chesapeake Dr, REDWOOD CITY, CA 94063-4739, United States. The medical device company can be reached via phone at +1-650-3632400 or via email at [email protected]


MarketBeat Community Rating for Avinger (AVGR)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  189 (Vote Outperform)
Underperform Votes:  144 (Vote Underperform)
Total Votes:  333
MarketBeat's community ratings are surveys of what our community members think about Avinger and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Avinger (NASDAQ:AVGR) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.252.252.252.25
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/A$200.00$200.00$200.00
Price Target Upside: N/A32,478.60% upside32,478.60% upside32,478.60% upside

Avinger (NASDAQ:AVGR) Consensus Price Target History

Price Target History for Avinger (NASDAQ:AVGR)

Avinger (NASDAQ:AVGR) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/14/2017CowenReiterated RatingBuyN/AView Rating Details
4/12/2017CIBCDowngradeOutperform -> Market PerformHighView Rating Details
4/12/2017OppenheimerReiterated RatingOutperform -> Market PerformHighView Rating Details
4/11/2017Canaccord GenuityDowngradeBuy -> HoldHighView Rating Details
8/15/2016BTIG ResearchReiterated RatingBuy$720.00 -> $240.00N/AView Rating Details
(Data available from 2/22/2016 forward)

Earnings

Avinger (NASDAQ:AVGR) Earnings History and Estimates Chart

Earnings by Quarter for Avinger (NASDAQ:AVGR)

Avinger (NASDAQ AVGR) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/5/2018N/AView Earnings Details
11/9/2017Q3 2017($17.20)$2.07 millionViewN/AView Earnings Details
8/8/2017Q2 2017($18.40)($20.80)$2.90 million$2.46 millionViewN/AView Earnings Details
5/4/2017Q1 2017($29.20)($25.60)$3.50 million$3.49 millionViewN/AView Earnings Details
3/6/2017Q4 2016($22.00)($23.20)$4.70 million$4.68 millionViewListenView Earnings Details
11/3/2016Q3($33.60)($29.20)$4.90 million$5.30 millionViewN/AView Earnings Details
8/1/2016Q2($46.00)($42.40)$3.05 million$4.70 millionViewListenView Earnings Details
5/4/2016Q1($46.80)($51.20)$2.90 million$4.54 millionViewListenView Earnings Details
3/1/2016Q4($41.60)($42.80)$3.10 million$2.86 millionViewListenView Earnings Details
11/5/2015Q315($35.20)($43.20)$3.10 million$2.70 millionViewListenView Earnings Details
7/28/2015Q215($46.40)($33.20)$2.72 million$3.00 millionViewListenView Earnings Details
5/6/2015Q1($46.00)($61.20)$2.30 million$2.09 millionViewListenView Earnings Details
3/12/2015Q414($30.00)($1,344.80)$3.10 million$3.07 millionViewListenView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Avinger (NASDAQ:AVGR) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Avinger (NASDAQ:AVGR)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Avinger (NASDAQ AVGR) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 4.80%
Insider Trades by Quarter for Avinger (NASDAQ:AVGR)
Institutional Ownership by Quarter for Avinger (NASDAQ:AVGR)

Avinger (NASDAQ AVGR) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/15/2017John B Ph D Md SimpsonInsiderSell1,074,130$0.25$268,532.50View SEC Filing  
11/13/2017John B Ph D Md SimpsonChairmanSell454,584$0.27$122,737.68View SEC Filing  
8/16/2016Jeffrey M SoinskiCEOBuy57,100$3.50$199,850.0059,345View SEC Filing  
8/16/2016Matthew FergusonCFOBuy7,000$3.50$24,500.0025,754View SEC Filing  
5/6/2016Donald A LucasDirectorSell9,309$12.58$117,107.22View SEC Filing  
5/6/2016Himanshu PatelInsiderSell10,000$13.40$134,000.0087,220View SEC Filing  
4/15/2016John B Ph D Md SimpsonMajor ShareholderSell75,111$13.11$984,705.21View SEC Filing  
3/11/2016John B Ph D Md SimpsonMajor ShareholderSell40,000$11.44$457,600.00View SEC Filing  
3/11/2016Matthew FergusonCFOBuy1,500$11.37$17,055.0017,754View SEC Filing  
12/14/2015Donald A LucasDirectorSell2,500$16.22$40,550.00View SEC Filing  
12/11/2015Donald A LucasDirectorSell4,000$15.92$63,680.00View SEC Filing  
11/25/2015John B Ph D Md SimpsonMajor ShareholderSell100,000$17.26$1,726,000.00View SEC Filing  
11/24/2015John B Ph D Md SimpsonChairmanSell42,445$17.20$730,054.00View SEC Filing  
2/4/2015Himanshu PatelCTOSell1,731$13.00$22,503.00View SEC Filing  
2/4/2015James CullenDirectorSell2,307$13.00$29,991.00View SEC Filing  
2/4/2015Matthew FergusonCFOSell1,154$13.00$15,002.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Avinger (NASDAQ AVGR) News Headlines

Source:
DateHeadline
OPS Code Established for Peripheral Vascular OCT Imaging in GermanyOPS Code Established for Peripheral Vascular OCT Imaging in Germany
finance.yahoo.com - February 20 at 9:38 AM
Avinger Announces Pricing of $18 Million Underwritten Public OfferingAvinger Announces Pricing of $18 Million Underwritten Public Offering
finance.yahoo.com - February 14 at 3:22 PM
REFILE-BRIEF-Avinger Files For Offering 15,000 Shares Of Series B Convertible Preferred Stock‍REFILE-BRIEF-Avinger Files For Offering 15,000 Shares Of Series B Convertible Preferred Stock‍
www.reuters.com - February 13 at 3:20 PM
Avinger’s Next Generation Pantheris Featured in Live Case Transmission at Leipzig Interventional Course 2018Avinger’s Next Generation Pantheris Featured in Live Case Transmission at Leipzig Interventional Course 2018
finance.yahoo.com - February 2 at 3:21 PM
Avinger (AVGR) Announces 1-for-40 Reverse Stock SplitAvinger (AVGR) Announces 1-for-40 Reverse Stock Split
www.streetinsider.com - January 31 at 5:58 AM
Avinger Announces Reverse Stock SplitAvinger Announces Reverse Stock Split
finance.yahoo.com - January 31 at 5:58 AM
Does Avinger Inc’s (NASDAQ:AVGR) Past Performance Indicate A Stronger Future?Does Avinger Inc’s (NASDAQ:AVGR) Past Performance Indicate A Stronger Future?
finance.yahoo.com - January 22 at 3:23 PM
Avinger (AVGR) Says it Was Granted Continued Listing Decision From NasdaqAvinger (AVGR) Says it Was Granted Continued Listing Decision From Nasdaq
www.streetinsider.com - January 20 at 1:52 PM
Did Avinger Inc’s (NASDAQ:AVGR) Recent Earnings Growth Beat The Trend?Did Avinger Inc’s (NASDAQ:AVGR) Recent Earnings Growth Beat The Trend?
finance.yahoo.com - January 19 at 10:37 AM
Avinger Inc (AVGR) Sees Large Growth in Short InterestAvinger Inc (AVGR) Sees Large Growth in Short Interest
www.americanbankingnews.com - January 14 at 3:40 AM
Avinger (AVGR) Downgraded to Hold at Zacks Investment ResearchAvinger (AVGR) Downgraded to Hold at Zacks Investment Research
www.americanbankingnews.com - January 11 at 7:08 PM
Avinger (AVGR) Upgraded by Zacks Investment Research to "Buy"Avinger (AVGR) Upgraded by Zacks Investment Research to "Buy"
www.americanbankingnews.com - January 3 at 5:40 PM
Avinger, Inc. (AVGR)Avinger, Inc. (AVGR)
finance.yahoo.com - January 3 at 3:42 PM
Avinger Announces Treatment of First Patients Globally With Next Generation PantherisAvinger Announces Treatment of First Patients Globally With Next Generation Pantheris
finance.yahoo.com - January 3 at 10:45 AM
What Should You Know About The Future Of Avinger Inc’s (NASDAQ:AVGR) Business?What Should You Know About The Future Of Avinger Inc’s (NASDAQ:AVGR) Business?
finance.yahoo.com - January 2 at 4:02 PM
Avinger (AVGR) Reports 510(k) Filing of Next Generation Pantheris Device - StreetInsider.comAvinger (AVGR) Reports 510(k) Filing of Next Generation Pantheris Device - StreetInsider.com
www.streetinsider.com - December 22 at 4:56 PM
Avinger Inc Announces CE Mark Clearance of Next Generation Pantheris Lumivascular Atherectomy System; Shares Soar 10%Avinger Inc Announces CE Mark Clearance of Next Generation Pantheris Lumivascular Atherectomy System; Shares Soar 10%
finance.yahoo.com - December 21 at 11:23 AM
Avinger Announces 510(k) Filing of Next Generation Pantheris DeviceAvinger Announces 510(k) Filing of Next Generation Pantheris Device
finance.yahoo.com - December 21 at 11:23 AM
Avinger Receives CE Marking Approval for Next Generation Pantheris Image-Guided Atherectomy Device - GlobeNewswire (press release)Avinger Receives CE Marking Approval for Next Generation Pantheris Image-Guided Atherectomy Device - GlobeNewswire (press release)
globenewswire.com - December 20 at 3:41 PM
Avinger (AVGR) Announces CE Marking Approval for Pantheris ... - StreetInsider.comAvinger (AVGR) Announces CE Marking Approval for Pantheris ... - StreetInsider.com
www.streetinsider.com - December 20 at 3:41 PM
Avinger Receives CE Marking Approval for Next Generation Pantheris Image-Guided Atherectomy DeviceAvinger Receives CE Marking Approval for Next Generation Pantheris Image-Guided Atherectomy Device
finance.yahoo.com - December 20 at 11:23 AM
Avinger Secures Waiver and Consent to CRG Loan Agreement - GlobeNewswire (press release)Avinger Secures Waiver and Consent to CRG Loan Agreement - GlobeNewswire (press release)
globenewswire.com - December 16 at 3:41 PM
Avinger Announces Change in Board Leadership Nasdaq:AVGR - GlobeNewswire (press release)Avinger Announces Change in Board Leadership Nasdaq:AVGR - GlobeNewswire (press release)
globenewswire.com - December 12 at 12:00 PM
Avinger, Inc. :AVGR-US: Earnings Analysis: Q3, 2017 By the Numbers : November 21, 2017Avinger, Inc. :AVGR-US: Earnings Analysis: Q3, 2017 By the Numbers : November 21, 2017
finance.yahoo.com - November 21 at 4:46 PM
Insider Selling: Avinger, Inc. (AVGR) Chairman Sells 454,584 Shares of StockInsider Selling: Avinger, Inc. (AVGR) Chairman Sells 454,584 Shares of Stock
www.americanbankingnews.com - November 15 at 10:29 PM
Insider Selling: Avinger, Inc. (AVGR) Insider Sells 1,074,130 Shares of StockInsider Selling: Avinger, Inc. (AVGR) Insider Sells 1,074,130 Shares of Stock
www.americanbankingnews.com - November 15 at 10:29 PM
Avinger Announces Third Quarter 2017 Results - GlobeNewswire (press release)Avinger Announces Third Quarter 2017 Results - GlobeNewswire (press release)
globenewswire.com - November 10 at 1:29 PM
Edited Transcript of AVGR earnings conference call or presentation 9-Nov-17 9:30pm GMTEdited Transcript of AVGR earnings conference call or presentation 9-Nov-17 9:30pm GMT
finance.yahoo.com - November 10 at 1:29 PM
Why Avinger Inc’s (AVGR) Investor Composition Impacts Your ReturnsWhy Avinger Inc’s (AVGR) Investor Composition Impacts Your Returns
finance.yahoo.com - November 9 at 5:23 PM
Avinger Announces Third Quarter 2017 ResultsAvinger Announces Third Quarter 2017 Results
finance.yahoo.com - November 9 at 5:23 PM
Avinger reports 3Q lossAvinger reports 3Q loss
finance.yahoo.com - November 9 at 5:23 PM
ETFs with exposure to Avinger, Inc. : November 8, 2017ETFs with exposure to Avinger, Inc. : November 8, 2017
finance.yahoo.com - November 8 at 6:31 PM
Avinger (AVGR) Announces $15M Max Common Share Purchase Agreement with Lincoln Park Capital - StreetInsider.comAvinger (AVGR) Announces $15M Max Common Share Purchase Agreement with Lincoln Park Capital - StreetInsider.com
www.streetinsider.com - November 6 at 10:12 PM
Avinger Enters into Common Stock Purchase Agreement for up to $15.0 Million with Lincoln Park CapitalAvinger Enters into Common Stock Purchase Agreement for up to $15.0 Million with Lincoln Park Capital
finance.yahoo.com - November 6 at 5:10 PM
Avinger (AVGR) Receives 510(k) Clearance for Design Modifications of PantherisAvinger (AVGR) Receives 510(k) Clearance for Design Modifications of Pantheris
www.streetinsider.com - November 2 at 4:49 PM
Avinger, Inc. (AVGR) Set to Announce Quarterly Earnings on ThursdayAvinger, Inc. (AVGR) Set to Announce Quarterly Earnings on Thursday
www.americanbankingnews.com - November 2 at 4:20 AM
Avinger to Announce Third Quarter 2017 Results on November 9, 2017 - GlobeNewswire (press release)Avinger to Announce Third Quarter 2017 Results on November 9, 2017 - GlobeNewswire (press release)
globenewswire.com - October 31 at 5:22 PM
Avinger (AVGR) Receives 510(k) Clearance for Design Modifications of Pantheris - StreetInsider.comAvinger (AVGR) Receives 510(k) Clearance for Design Modifications of Pantheris - StreetInsider.com
www.streetinsider.com - October 31 at 5:22 PM
Avinger Receives 510(k) Clearance for Design Modifications to Enhance Performance of Pantheris Image-Guided Atherectomy DeviceAvinger Receives 510(k) Clearance for Design Modifications to Enhance Performance of Pantheris Image-Guided Atherectomy Device
finance.yahoo.com - October 31 at 5:22 PM
Avinger, Inc. (AVGR) Sees Significant Drop in Short InterestAvinger, Inc. (AVGR) Sees Significant Drop in Short Interest
www.americanbankingnews.com - October 27 at 1:40 AM
Avinger, Inc. (AVGR) Scheduled to Post Quarterly Earnings on WednesdayAvinger, Inc. (AVGR) Scheduled to Post Quarterly Earnings on Wednesday
www.americanbankingnews.com - October 25 at 6:30 AM
Avinger Announces First Patient Enrolled in its IDE Study of the Pantheris Image-Guided Atherectomy System for Treatment of In-Stent RestenosisAvinger Announces First Patient Enrolled in its IDE Study of the Pantheris Image-Guided Atherectomy System for Treatment of In-Stent Restenosis
finance.yahoo.com - October 19 at 4:46 PM
Edited Transcript of AVGR earnings conference call or presentation 4-May-17 8:30pm GMTEdited Transcript of AVGR earnings conference call or presentation 4-May-17 8:30pm GMT
finance.yahoo.com - October 17 at 5:04 PM
ETFs with exposure to Avinger, Inc. : October 11, 2017ETFs with exposure to Avinger, Inc. : October 11, 2017
finance.yahoo.com - October 11 at 5:45 PM
Avinger Receives CE Marking Approval for In-Stent Restenosis Treatment Indication With Pantheris Image-Guided AtherectomyAvinger Receives CE Marking Approval for In-Stent Restenosis Treatment Indication With Pantheris Image-Guided Atherectomy
finance.yahoo.com - October 2 at 4:10 PM
ETFs with exposure to Avinger, Inc. : September 28, 2017ETFs with exposure to Avinger, Inc. : September 28, 2017
finance.yahoo.com - October 2 at 4:10 PM
CE Mark Sparks Avinger, Shares Soar 130%CE Mark Sparks Avinger, Shares Soar 130%
www.baystreet.ca - September 28 at 9:38 PM
FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Avinger, Inc. (AVGR) and Lead Plaintiff Deadline: September 5, 2017FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Avinger, Inc. (AVGR) and Lead Plaintiff Deadline: September 5, 2017
finance.yahoo.com - September 5 at 5:50 PM
INVESTOR ALERT: Goldberg Law PC Announces a Securities Class Action Lawsuit against Avinger, Inc.INVESTOR ALERT: Goldberg Law PC Announces a Securities Class Action Lawsuit against Avinger, Inc.
feeds.benzinga.com - September 2 at 12:39 AM
Scott+Scott, Attorneys at Law, LLP Reminds Investors of Upcoming September 5th Deadline for Lead Plaintiff Motions in Securities Class Action Against Avinger, Inc. (AVGR)Scott+Scott, Attorneys at Law, LLP Reminds Investors of Upcoming September 5th Deadline for Lead Plaintiff Motions in Securities Class Action Against Avinger, Inc. (AVGR)
finance.yahoo.com - August 30 at 5:29 PM

SEC Filings

Avinger (NASDAQ:AVGR) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Avinger (NASDAQ:AVGR) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Avinger (NASDAQ AVGR) Stock Chart for Thursday, February, 22, 2018

Loading chart…

This page was last updated on 2/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.